CAU senior professor and PMI cluster member receives high distinction for his life's work
Professor Thomas F. Meyer, member of the Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) and Senior Professor at the Medical Faculty of the Christian-Albrechts-University of Kiel (CAU), was awarded the Robert Koch Medal in Gold on Saturday (14.11.2020). The award is one of the highest scientific distinctions in the field of infectious medicine; among the prize winners are several later Nobel Prize winners. With the medal, the Robert Koch Foundation honors the outstanding scientific life's work of Professor Meyer, who to this day has set milestones in infection research up to the discovery of causative mechanisms of cancer development.
Professor Dr. Thomas F. Meyer
Institute of Clinical Molecular Biology (IKMB)
Kiel University (CAU) and University Medical Center Schleswig-Holstein (UKSH)
- unizeit #104: Infections, inflammations and cancer
- Press information (08.06.2020): Professor Meyer receives the Robert Koch Gold Medal for his life's work
- Press information (01.09.2020): Professor Meyer becomes senior professor at the Faculty of Medicine at the CAU
- The Robert Koch Foundation about the laureates 2020
About the Cluster of Excellence PMI
The Cluster of Excellence "Precision Medicine in Chronic Inflammation" (PMI) is being funded from 2019 to 2025 through the German Excellence Strategy (ExStra). It succeeds the "Inflammation at Interfaces” Cluster, which was already funded in two periods of the Excellence Initiative (2007-2018). Around 300 members from eight institutions at four locations are involved: Kiel (Kiel University, University Medical Center Schleswig-Holstein (UKSH), Muthesius University of Fine Arts and Design, Kiel Institute for the World Economy (IfW), Leibniz Institute for Science and Mathematics Education (IPN)), Lübeck (University of Lübeck, University Medical Center Schleswig-Holstein (UKSH)), Plön (Max Planck Institute for Evolutionary Biology) and Borstel (Research Center Borstel - Leibniz Lung Center).
The goal is to translate interdisciplinary research findings on chronic inflammatory diseases of barrier organs to healthcare more intensively, as well as to fulfil previously unsatisfied needs of the patients. Three points are important in the context of successful treatment, and are therefore at the heart of PMI research: the early detection of chronic inflammatory diseases, the prediction of disease progression and complications, and the prediction of individual responses to treatment.